Abacus Total Parenteral Nutrition Calculation Software 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Baxa Corporation 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2012-05-28
  • 사례 출판 날짜
    2012-05-28
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: baxa abacus total parenteral nutrition calculation software the food and drug administration (fda), united states issued a class i medical device recall concerning abacus total parenteral nutrition (tpn) calculation software [catalogue no: 8300-0045: abacus calculator only (abacus ce); 8300-0046: abacus single work station (abacus se); 8300-0047: abacus multi-work station (abacus me)] manufactured by baxa corporation. according to the fda, the abacus tpn calculating software is an fda class i laboratory information management system windows-based program used in ordering total parenteral nutrition. according to the manufacturer, a number of errors have been reported by abacus software users as a result of ordering salt based parenteral nutrition ingredients on an ion based ordering template. abacus tpn calculation software is designed and intended to allow the ordering of electrolytes in only one of two ways: as a salt (such as calcium gluconate 10%) or as an elemental ion (such as calcium). however, if a dosage is entered into the system based on one method, when the template is configured for the other method, a dosing error can occur. the problem associated with mix-ups related to salt-based or ion-based ordering of electrolytes is not exclusive to calcium gluconate. for details, please visit the following fda website: http://www.Fda.Gov/medicaldevices/safety/listofrecalls/ucm305744.Htm according to the local supplier, the affected device was not distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted 28 may 2012.

Device

Manufacturer